Natco Pharma plans to launch generic Risdiplam pending Delhi High Court decision, offering discounts to patients.

Natco Pharma updates on Risdiplam launch in India, Delhi High Court denies Roche's injunction plea, pricing set at ₹15,900.

The company said it has decided to price its version of Risdiplam product at Rs 15,900, and further added that it intends to ...

India’s benchmark indices bounced back strongly on Tuesday, recouping overnight losses to end over 1.5% higher. The Sensex ...

India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to ...

The stock rose 2.95 per cent to hit a high of Rs 789. It was last seen trading 1.44 per cent up at Rs 777.45. At this price, ...

Shares of Infonative Solutions were trading at Rs 60.04 on the BSE, a discount of 24% compared with the issue price of Rs 79.

The Company has received numerous enquiries from investors and patients about the launch, availability and pricing of generic version of Risdiplam in the Indian market. The Company wishes to clarify ...

The Indian QR coding programme introduced in 2023 to detect counterfeit medicines will instead now cause great harm.